Waypoint Capital Advisors »

Apogee Therapeutics shares owned by Waypoint Capital Advisors

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Waypoint Capital Advisors from 13F filings

Historical chart of Waypoint Capital Advisors investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Waypoint Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Waypoint Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $37M 627k 58.74

More positions owned by Waypoint Capital Advisors

American Centy Etf Tr Intl Eqt Etf (AVDE)
Apogee Therapeutics (APGE)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
American Centy Etf Tr Us Eqt Etf (AVUS)
American Centy Etf Tr Avantis Us Larg (AVLC)
Dimensional Etf Trust Intl Core Equity (DFIC)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Apple (AAPL)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Ishares Tr S&p 100 Etf (OEF)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
American Centy Etf Tr Avantis Us Small (AVSC)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)

View all positions for Waypoint Capital Advisors

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
Rtw Investments
BlackRock
Vanguard Group
Driehaus Capital Management
Fairmount Funds Management
State Street Corporation
Paradigm Biocapital Advisors
Braidwell
Alliancebernstein
Perceptive Advisors
Citadel Advisors
Affinity Asset Advisors

View all funds holding Apogee Therapeutics